News

The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...
The drug, Dawnzera, is approved to prevent symptoms of a rare genetic disease called hereditary angioedema (HAE) in adults and pediatric patients over 12 years old. The condition causes frequent ...
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...
Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic condition, hereditary angioedema.
Rhythm Pharmaceuticals (NASDAQ:RYTM) announced that U.S. and EU regulators have accepted for review a potential label ...
A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The ...
U.S. health officials gave the Food and Drug Administration the power to quickly authorize veterinarians and farmers to treat ...
The FDA has agreed to speed up a review of a rare disease drug developed by Stealth BioTherapeutics, a notable step after the company said it may have to close its doors otherwise.
The Food and Drug Administration (FDA) became authorized Tuesday to allow the use of animal drugs to treat or prevent ...
The FDA urged consumers not to use the foam-style products because they may not be effective in protecting the skin from the ...
Bristol Myers Squibb and SystImmune have announced breakthrough therapy designation from the US Food and Drug Administration ...